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‘Dr Granville’s mummy’ was described to the Royal Society of London in 1825 and was the ﬁrst ancient
Egyptian mummy to be subjected to a scientiﬁc autopsy. The remains are those of a woman, Irtyersenu,
aged about 50, from the necropolis of Thebes and dated to about 600 BC. Augustus Bozzi Granville
(1783–1872), an eminent physician and obstetrician, described many organs still in situ and attributed
the cause of death to a tumour of the ovary. However, subsequent histological investigations indicate that the
tumour is a benign cystadenoma. Histology of the lungs demonstrated a potentially fatal pulmonary exudate
and earlier studies attempted to associate this with particular disease conditions. Palaeopathology and
ancient DNA analyses show that tuberculosis was widespread in ancient Egypt, so a systematic search for
tuberculosis was made, using speciﬁc DNA and lipid biomarker analyses. Clear evidence for Mycobacterium
tuberculosis complex DNA was obtained in lung tissue and gall bladder samples, based on nested PCR of the
IS6110 locus. Lung and femurs were positive for speciﬁc M. tuberculosis complex cell-wall mycolic acids,
demonstrated by high-performance liquid chromatography of pyrenebutyric acid–pentaﬂuorobenzyl
mycolates. Therefore, tuberculosis is likely to have been the major cause of death of Irtyersenu.
Keywords: ancient DNA; ancient Egypt; Granville mummy; high-performance liquid chromatography;
Mycobacterium tuberculosis; mycolic acid
1. INTRODUCTION
The presentation made by Augustus Bozzi Granville to
the Fellows of the Royal Society (Granville 1825)w a s
the culmination of a study that had aroused great public
interest and laid the foundations of the scientiﬁc study
of ancient Egyptian mummies. Earlier descriptions of
mummies, attempts to describe the wrappings and
materials used in mummiﬁcation and the exterior state
of the human remains, were fully reviewed by Granville.
However, he was fortunate to gain access to a particularly
well-preserved specimen (ﬁgure 1a,b) and had the pre-
requisite medical knowledge to take full advantage of this
opportunity. The mummy, from the necropolis of
Thebes, was of the lady Irtyersenu, of the 26th Dynasty,
dated to ca 600 BC (Hedges et al. 1997). After detailed
observations of the wrappings and the exterior features
of the mummy, Granville decided to perform a detailed
(but destructive) autopsy. As he stated (Granville 1825,
p. 281):
Having proceeded thus far into my inquiry into the state
of preservation of the mummy before me, I determined,
perfect and beautiful as it was, to make it the object of
further research by subjecting it to the anatomical knife,
and thus to sacriﬁce a most complete specimen of the
art of Egyptian embalming, in hopes of eliciting some
new facts illustrative of so curious and interesting a
subject;
Granville, who was an eminent physician and obstetri-
cian, observed that the mummy was that of a woman
aged around 50, who had been corpulent. She showed
signs of what we now recognize as osteoporosis, but of par-
ticular interest was a mass around the right ovary, which
Granville described as ‘ovarian dropsy’ or cancer and led
tohisconclusionthatthiswasthecauseofdeath.However,
more recent studies (Strouhal 1976; Nunn & Tapp 2000)
suggest that this was a benign cystadenoma of the ovary,
which would not have been fatal.
The residual organs and bones of the Granville
mummy were displayed in a wooden cabinet, which is
now in the British Museum in London. Further studies
were carried out in 1994 and subsequent years, which
are described in a book due to be published by the British
Museum Press (Harer & Taylor in press). The histological
studies of the mummy tissues mentioned above noted a
potentially fatal pathological condition—a pulmonary
exudate (Tapp in press). In an attempt to determine the
cause of death, further investigations were carried out.
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was tested using the ParaSight-F-test for Plasmodium
falciparum histidine-rich protein-2. A positive ﬁnding
suggested that the lady Irtyersenu was suffering from
untreated P . falciparum malaria when she died (Miller
et al. 1994). However, it was subsequently discovered
that this test gives false-positive reactions in the presence
of serum rheumatoid factor (Laferl et al. 1997; Bianucci
et al. 2008). During the early 1990s, several attempts
were made to detect microbial or human DNA from the
Granville mummy by PCR. These remain unpublished
as negative results were obtained and investigators con-
cluded that the extracts were strongly inhibitory to
DNA ampliﬁcation. As part of a broader study on histori-
cal and ancient malaria, a subsequent attempt to detect
P . falciparum DNA from the Granville mummy was
inconclusive (Taylor et al. 1997).
Tuberculosis has long been recognized in Egyptian
mummies by palaeopathological changes, such as Pott’s
disease, and Mycobacterium tuberculosis complex DNA
has been detected and characterized from the Predynastic
era (Crube ´zy et al. 1998), the Old, Middle and New
Kingdoms (Nerlich et al. 1997; Zink et al. 2003a). There-
fore, the aim of this study was to determine whether the
lady Irtyersenu had evidence of tuberculosis in her
tissues, which may have been her cause of death. Because
of the reported difﬁculty of obtaining ampliﬁable
DNA from this mummy, an additional method was
used: the direct detection of speciﬁc cell-wall mycolic
acid biomarkers of the M. tuberculosis complex, using
high-performance liquid chromatography (HPLC).
This has been used previously to conﬁrm cases of tuber-
culosis indicated by M. tuberculosis complex DNA
(Donoghue et al. 1998; Gernaey et al. 2001) and the tech-
nique has recently been reﬁned and increased in
sensitivity, thereby permitting the direct detection and
quantiﬁcation of M. tuberculosis complex mycolic acid
derivatives in human remains 9000 years old (Hershkovitz
et al. 2008).
2. MATERIAL AND METHODS
(a) Samples
Samples taken in the early 1990s were available—lung tissue,
and bone from the left and right femurs and the hand of
the Granville mummy. In addition, additional samples were
collected from the lung, gall bladder and soft tissues that
may be of pleura or diaphragm. Samples were examined
independently at UCL (DNA analysis) and University of
Birmingham (cell-wall mycolic acid biomarkers).
(b) Precautions against contamination
The recommended protocols of ancient DNA (aDNA)
work (O’Rourke et al. 2000; Donoghue & Spigelman 2006;
(a)( b)
Figure 1. The original appearance of the Granville mummy. (a) Inner cofﬁn lid; (b) unwrapped mummy (Granville 1825).
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processed in laboratories where no work with modern
M. tuberculosis has ever been performed. There was strict sep-
aration of work areas between DNA extraction, PCR set-up,
nested and post-PCR procedures using different laboratories,
demarcated by labels, colour of laboratory coats and backed
up by staff training. Within laboratories, strict guidelines
were followed regarding cleaning and non-sharing of equip-
ment. Dedicated sets of pipettes were used for PCR set-up
and were stripped and cleaned in detergent and ethanol
before each experiment. Fresh sterile ﬁlter tips were used
routinely. Surfaces and equipment in contact with sample
tubes (centrifuges, rotors, mixers, etc.) were cleaned before
each assay and use of sterile and pre-purchased reagents
minimized contamination risk.
(c) DNA extraction
DNA extraction procedures have been described previously
(Donoghue et al. 2005). Three separate extractions were
performed (electronic supplementary material, table S1). In
brief, approximately 25 mg of sample was pre-incubated in
Proteinase K/EDTA at 568C for 24–72 h. Owing to the
reported difﬁculty of obtaining ampliﬁable DNA from this
material, an aliquot from each sample was treated with
0.1 M N-phenacylthiazolium bromide, a reagent that cleaves
glucose-derived protein cross-links (Poinar et al. 1998).
Thereafter, all samples were lysed in guanidium thiocyanate
solution at 568C( Boom et al. 1990) and vigorously mixed
with small glass beads to release any mycobacterial DNA.
DNA was captured onto silica by using spin columns
(DNeasy tissue kit, Qiagen Ltd). After washing and drying,
DNA was eluted from the silica, aliquoted and used immedi-
ately or stored at 2208C. Negative extraction controls were
always included.
(d) DNA ampliﬁcation and detection
The M. tuberculosis complex was detected by targeting a
speciﬁc region of the repetitive element IS6110 (Eisenach
et al. 1990; Hellyer et al. 1996). A two-tube nested PCR
was used, which yielded an outer product of 123 bp and a
nested PCR product of 92 bp (Spigelman & Lemma 1993;
Taylor et al. 1996). The PCR mix included 10 mM bovine
serum albumin to reduce PCR inhibition (Forbes & Hicks
1996; Abu Al-Soud & Ra ˚dstro ¨m 2000). A 50 ml reaction
mix was used with 5 ml of DNA extract. Tenfold dilutions
of DNA extract were also tested to reduce any inhibition.
In a parallel set of experiments, 1 M betaine was included
in the PCR mix as a facilitator (Weissensteiner & Lanchbury
1996). A hot-start Taq polymerase was used to minimize
non-speciﬁc primer and template binding. Negative controls
were always included. PCR product was detected by staining
with ethidium bromide and visualized under ultraviolet light.
In order to characterize the predominant DNA molecule,
direct sequencing of the whole PCR amplicon was performed
by MWG-BIOTECH AG (Ebersberg, Germany).
(e) Mycolic acid derivatization and high-performance
liquid chromatography analysis
Extracts of a stored lung tissue sample taken previously
(sample 1: 29.6 mg), a new lung sample (sample 2:
69.9 mg) and combined left and right femurs (71.2 mg)
wereanalysedbyHPLCfor mycolicacids.Thedetailedproto-
cols have been described previously (Hershkovitz et al. 2008).
In brief, samples were hydrolysed and long-chain fatty acids
derivatized to pentaﬂuorobenzyl (PFB) esters by established
procedures (Minnikin et al. 1993). PFB mycolate fractions
were isolated using normal phase cartridges and reacted with
pyrenebutyric acid (PBA) to give PBA–PFB-derivatized
mycolates, which, after standard clean-up procedures, were
examined by reverse-phase HPLC for proﬁles similar to stan-
dard M. tuberculosis. It has been established that modern
tuberculosis can be diagnosed by recognition of avery charac-
teristicreverse-phaseHPLCproﬁleofmycolicacids,shownby
members of the M. tuberculosis complex (Butler & Guthertz
2001). Such a diagnosis was reinforced by use of the
normal-phase HPLC to separate the individual alpha-,
methoxy- and keto-mycolates, followed by reverse-phase
HPLC of each of these components, as demonstrated
previously for modern (Minnikin et al. 1993) and ancient
lanes: 1 2 3
92 bp
4 5 6 7 8 9 10 11
Figure 2. Demonstration of M. tuberculosis complex DNA in
mummy lung sample. Lane 4: original lung sample showing a
92 bp nested PCR product speciﬁc for the M. tuberculosis
complex; lanes 1–3 and 5–8: old lung extracts stored at
2208C and thawed; lanes 9 and 10: negative extraction con-
trols; lane 11: 123 bp ladder.
total mycolates
lung sample 1
lung sample 2
femurs
M. tuberculosis
standard
blank
0 5 10 15 20 25
min
Figure 3. Detection of M. tuberculosis complex mycolic acid
PBA–PFB derivatives by reverse-phase ﬂuorescence
HPLC, from the Granville mummy femur and lung samples,
in comparison with a known standard strain of M. tuberculosis.
The characteristic tight envelopes of peaks are the total
mixture of homologues for the different alpha-, methoxy-
and keto-mycolates. The y-axis in the proﬁles represents
absorbance.
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The ﬁnal reverse-phase HPLC proﬁles were correlated with
precise structural data for M. tuberculosis complex mycolic
acids, recorded by Watanabe et al. (2002). Solvent blanks
were run after any positive sample to ensure that there was
no carry-over of material. The absolute amounts and percen-
tage ratios of mycolic acid types were calculated as described
previously (Hershkovitz et al. 2008).
3. RESULTS
Negative controls were satisfactory for both DNA and
HPLC analyses. DNA from the M. tuberculosis complex
was detected in the lung samples, gall bladder and mem-
branous tissues (possibly pleura and diaphragm) but
results were inconsistent (electronic supplementary
material, table S2). Additional characterization of the
DNA was not attempted as previously positive DNA
extracts lost activity after freezing and thawing, indicating
the fragility of the DNA. A positive result from the orig-
inal lung tissue is shown on an agarose gel (ﬁgure 2).
DNA sequences were obtained from the nested PCR pro-
ducts of the original lung sample, gall bladder and
possible diaphragm, which were homologous with that
in the NCBI database (electronic supplementary
material, ﬁg. S1a–c).
The HPLC results for the analysis of extracts of com-
bined left and right femurs and a new lung sample are
shown in reverse-phase (ﬁgure 3), normal-phase (ﬁgure 4)
and subsequent reverse-phase HPLC (ﬁgure 5). There
was a good correlation between the proﬁles from each
sample, with the M. tuberculosis positive standard, clearly
demonstratingthepresenceofspeciﬁcbiomarkersfortuber-
culosis. The absolute amounts of mycolates in each sample
were calculated (table 1). Lung sample 1 contained about
twice the level of mycolates in sample 2 and a weaker
signal was obtained from the combined femur samples.
The proportions of alpha-, methoxy- and keto-mycolates
(table 2) again correlated well with those from standard
M. tuberculosis in the stronger lung sample 1, and the
weaker samples followed the same trend.
4. DISCUSSION
The tissue samples used in these studies contained a rela-
tively large quantity of what seemed to be insoluble
foreign substances introduced during mummiﬁcation.
For example, the samples of original lung and gall bladder
were noticeably oily. This mummy was unusual as it still
had most of its internal organs in situ (Granville 1825).
Therefore, the process of mummiﬁcation appears to
have differed from the norm. Granville believed that
after initial dehydration with natron, the main material
used was bitumen, possibly mixed with beeswax, but an
analysis of embalming residues from the mummy has
found no traces of either substance (Harer & Taylor in
press). It is possible that the unusual process employed
by the embalmers on this body has affected the retrieval
of ampliﬁable DNA, as it has been readily obtained
from other archaeological specimens from the Theban
necropolis.
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Figure 5. Reverse-phase HPLC analyses of the collected frac-
tions from the normal-phase HPLC separation, from the
Granville mummy femur and lung samples, in comparison
with a known standard strain of M. tuberculosis.( a) Alpha-
mycolates, (b) methoxy-mycolates and (c) keto-mycolates.
The y-axis in the proﬁles represents absorbance.
lung sample 1 keto-
?
methoxy-
alpha-
lung sample 2
femurs
M. tuberculosis standard
blank
0 5 10 15 20 25
min
Figure 4. Normal-phase HPLC analyses of the collected total
mycolates from the reverse-phase separation, from the Gran-
ville mummy femur and lung samples, in comparison with a
known standard strain of M. tuberculosis. The y-axis in the
proﬁles represents absorbance. The question mark indicates
an unidentiﬁed peak.
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and M. tuberculosis complex DNA has been found in the
young and old, from high- and low-status burials. Where
additional molecular characterization has been possible
(Zink et al. 2001, 2003a,b), this has shown that human
lineages of the M. tuberculosis complex were present:
M. tuberculosis and possibly Mycobacterium africanum, but
not Mycobacterium bovis. This is consistent with our cur-
rent understanding of the evolution of the M. tuberculosis
complex and the long-term coexistence of human pop-
ulations with this microbial pathogen (Brosch et al. 2002;
Hershkovitz et al. 2008; Wirth et al. 2008). In the present
study, the M. tuberculosis complex was not further character-
ized owing to the difﬁculties described above. However, it is
likely that the lady Irtyersenu was infected with a strain of
M. tuberculosis of modern lineage, as these were prevalent in
the populations examined by Zink et al. (2003a).
The detection of M. tuberculosis complex cell-wall
mycolic acid biomarkers avoids the problems of DNA
analysis. The molecules are far more robust and the
method of analysis is sufﬁciently sensitive to permit
the direct detection of femtogram quantities of material.
Therefore, a direct biomarker analysis is an excellent
alternative procedure for the conﬁrmation of DNA ﬁnd-
ings. In addition, detection of lipid biomarkers appears
to have potential for the examination of archaeological
specimens that are too ancient or have been stored
under suboptimal conditions, where DNA detection is
not possible.
In the case of the Granville mummy, M. tuberculosis
complex DNA was detected in the lung tissue, gall blad-
der and tissues from possible pleura and diaphragm. The
HPLC data found the greatest quantity of M. tuberculosis
complex cell-wall mycolates in the lung tissue and lower
amounts in the femurs. Assuming that the pulmonary
exudate was the prime source of the infection, it appears
that the lady Irtyersenu had pulmonary tuberculosis that
had disseminated to other sites in the body. During the
second autopsy of Irtyersenu in 1994, it was noted that
fat was interspersed in her skeletal muscle, which is
indicative of wasting rather than obesity (Harer &
Taylor in press). This suggests a somewhat protracted
terminal illness and/or very sedentary lifestyle—both of
which are consistent with an active tuberculosis infection.
These molecular ﬁndings, combined with the histological
observations, support a diagnosis of terminal dissemi-
nated pulmonary tuberculosis, rather than the malaria
suggested by the second autopsy. Therefore, we are able
to enhance the original paper by Granville (1825) to the
Royal Society by concluding that there is evidence of an
active tuberculosis infection in the lady Irtyersenu and
that this, rather than a benign ovarian cystadenoma, was
likely to be the major cause of her death.
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